Mithra Pharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
David Solomon
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.8yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
David Solomon (63 yo)
less than a year
Tenure
Dr. David Horn Solomon, M.D., is Chief Executive Officer of Mithra Pharmaceuticals SA from April 11, 2023. He was the Chief Executive Officer of Pharnext SA since April 2020 until November 27, 2022 and ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | no data | no data | |
| Chief Financial Officer | 6.8yrs | no data | no data | |
| Chief of Operations | less than a year | no data | no data | |
| Chief Scientific Officer | 4.3yrs | no data | no data | |
| Compliance Officer | no data | no data | no data | |
| Chief Commercial & External Affairs Officer | 2.8yrs | no data | 0.000040% € 40.4 | |
| President of the Scientific Advisory Board & Executive Director | no data | €7.12k | 0.029% € 29.7k | |
| Secretary of the Board | no data | no data | no data |
2.8yrs
Average Tenure
Experienced Management: MITRAb's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President of the Scientific Advisory Board & Executive Director | 7.2yrs | €7.12k | 0.029% € 29.7k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Chairman | less than a year | no data | no data | |
| Non-Executive Director | 1.9yrs | €20.00k | 0.042% € 42.3k | |
| Independent Director | less than a year | no data | no data |
0.5yrs
Average Tenure
Experienced Board: MITRAb's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.